Myriad Genetics, Inc.
DETECTING CANCER RISK

Abstract:

The present disclosure relates to methods, kits, and systems for assessing the risk of a human subject for developing a cancer, including genetic risk assessment, clinical risk assessment, and combinations of both to improve risk analysis.